Gene · 1263
Papers1,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Specific gene module pair-based target identification and drug discovery. | Front Pharmacol | 2022 | 36726786 | PubTator, text mining | PubMed |
A high level of the long non-coding RNA MCF2L-AS1 is associated with poor prognosis in breast cancer and MCF2L-AS1 activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis. | Bioengineered | 2022 | 36700469 | PubTator, text mining | PubMed |
| Hypoxia signaling pathway: A central mediator in endocrine tumors. | Front Endocrinol (Lausanne) | 2022 | 36699028 | PubTator, text mining | PubMed |
| Polo-like kinase (PLK) 5, a new member of the PLK family, serves as a biomarker to indicate anabatic tumor burden and poor prognosis for resectable non-small cell lung cancer. | Front Surg | 2022 | 36684318 | PubTator, text mining | PubMed |
| PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas. | Front Oncol | 2022 | 36620611 | PubTator, text mining | PubMed |
| Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma. | Front Immunol | 2022 | 36618405 | PubTator, text mining | PubMed |
| Overview of Cancer Metabolism and Signaling Transduction. | Int J Mol Sci | 2022 | 36613455 | PubTator, text mining | PubMed |
| The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. | Cells | 2022 | 36611918 | PubTator, text mining | PubMed |
| Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis-An updated review. | Front Bioeng Biotechnol | 2022 | 36588956 | PubTator, text mining | PubMed |
| Multi-omics investigation reveals functional specialization of transcriptional cyclin dependent kinases in cancer biology. | Sci Rep | 2022 | 36577800 | PubTator, text mining | PubMed |
| ADAR1p110 promotes Enterovirus D68 replication through its deaminase domain and inhibition of PKR pathway. | Virol J | 2022 | 36550502 | PubTator, text mining | PubMed |
| Chaetoglobosin E inhibits tumor growth and promotes the anti-tumor efficacy of cytotoxic drugs in esophageal squamous cell carcinoma by targeting PLK1. | Ann Transl Med | 2022 | 36544631 | PubTator, text mining | PubMed |
| Hypermethylation of nc886 in HPV-positive oropharyngeal cancer and its clinical implications: An epigenome-wide association study. | Mol Ther Nucleic Acids | 2022 | 36514351 | PubTator, text mining | PubMed |
| Polo-like kinase 1 as a potential therapeutic target and prognostic factor for various human malignancies: A systematic review and meta-analysis. | Front Oncol | 2022 | 36457496 | PubTator, text mining | PubMed |
| Calreticulin in renal fibrosis: A short review. | J Cell Mol Med | 2022 | 36440574 | PubTator, text mining | PubMed |
| Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy. | Cancers (Basel) | 2022 | 36428594 | PubTator, text mining | PubMed |
| Morphology and gene expression profiling provide complementary information for mapping cell state. | Cell Syst | 2022 | 36395727 | PubTator, text mining | PubMed |
| Digital transformation of business model innovation. | Front Psychol | 2022 | 36389577 | PubTator, text mining | PubMed |
| The progress of protein synthesis factors eIFs, eEFs and eRFs in inflammatory bowel disease and colorectal cancer pathogenesis. | Front Oncol | 2022 | 36387239 | PubTator, text mining | PubMed |
| Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges. | Int J Mol Sci | 2022 | 36361743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1263/papers?page=11